General Court finds no risk of confusion between pharma marks containing ‘brez’/‘breez’ element
Legal updates: case law analysis and intelligence
The General Court underlined the particularly high level of attention of the relevant public when it comes to medicines that have a direct impact on their health.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10